Cargando…
A Normal FGF23 Does Not Preclude Tumor‐Induced Osteomalacia
Tumor‐induced osteomalacia (TIO) is a rare cause of impaired bone mineralization mediated by the osteocyte‐derived, phosphaturic hormone: fibroblast growth factor 23 (FGF23). The case is presented of a previously healthy 45‐year‐old man who developed fragility fractures at multiple sites (initially...
Autores principales: | Nandam, Neeharika, Ejaz, Sadia, Ahrens, William, Styner, Maya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872335/ https://www.ncbi.nlm.nih.gov/pubmed/33615107 http://dx.doi.org/10.1002/jbm4.10438 |
Ejemplares similares
-
SAT-385 A Normal FGF23 Does Not Preclude Tumor Induced Osteomalacia (TIO)
por: Nandam, Neeharika, et al.
Publicado: (2020) -
SAT-217 Paraganglioma in Two Unrelated Kinyarwanda-Speaking Patients in Anatomically Distinct Sites
por: Ejaz, Sadia, et al.
Publicado: (2020) -
A Study of Paraganglioma Cases With Non-European Ancestry
por: Ejaz, Sadia, et al.
Publicado: (2022) -
Tumor-Induced Osteomalacia With Normal Fibroblast Growth Factor-23 (FGF23) and Idiopathic Hypercalciuria
por: Velazquez-Navarro, Jassel A, et al.
Publicado: (2022) -
Selective blood sampling for FGF-23 in tumor-induced osteomalacia
por: Schober, Hans-Christof, et al.
Publicado: (2017)